Why the study?
Postoperative transthoracic echocardiographic screening is recommended after cardiac myxoma resection, but evidence regarding the appropriate duration or timing of follow-up strategies is limited.
Cardiac myxoma can recur and cause embolic stroke more than 10 years after initial resection, suggesting that prolonged echocardiographic surveillance may be beneficial.
Cardiac myxoma is the most common benign cardiac tumor. Although it has a very low reported incidence of 0.5-1 per 1,000,000 person-years, it is a potentially devastating cause of cardioembolic stroke. About 12% of cardiac myxoma cases are associated with neurologic disorders, most commonly ischemic stroke. 1 Surgical resection is the treatment of choice, and the recurrence rate was reportedly less than 1% per year, predominantly within 4 years. 2 Transthoracic echocardiographic screening is currently recommended in postoperative settings, but there is little evidence over appropriate duration or periods of follow-up strategies. Here we report a patient who presented with recurrent cardiac myxoma revealed by an embolic stroke event that occurred 12 years after complete resection, which had gone undetected during 9 years of routine echocardiographic follow-ups.
No takes yet. Share an insight, caveat, or question.
Guk et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: